Canberra-Sana
Australian researchers have developed a new test that can help fight skin cancer through immunotherapy, which is based on testing protein levels in cancer cells.
According to the Medical Express website, the study conducted by researchers at the Climmer Perovir Institute for Medical Research in Australia revealed that the new test works by testing the prototype levels of the protein "LC3B" in cancer cells, as higher levels are associated with better responses for patients to a form of treatment known as In the name of immunotherapy, which works to fight skin cancer.
The researchers pointed out that the new test aims to fight metastatic melanoma, which is the most dangerous type of skin cancer facing patients, because it affects the melanocytes that produce the pigment melanin that gives the skin its color and thus results in serious complications.
In their study, the researchers used tumor and blood samples collected from skin cancer patients before and after treatment to gain a better understanding of the role of the "LC3B" protein in metastatic melanoma and to develop a prototype test. They concluded that patients with this type of cancer had very high levels. Of the epigenetic enzyme and may improve more than those with low levels of this enzyme.
The researchers explained that immunotherapy has significantly improved treatment and survival rates for metastatic melanoma, as the study showed that 95 percent of patients with high levels of the "LC3B" protein remained alive after three years, compared to 60 percent of patients with low levels. Of protein.
